Abstract Number: 0205 • ACR Convergence 2021
An Observational Study from the Perspective of Rheumatology in the Management of Patients with Psoriatic Arthritis in Turkey – LOOP Study
Background/Purpose: Available evidence suggests that timely and effective management of patients with psoriatic arthritis (PsA) can improve long-term outcomes. Current information on the factors which…Abstract Number: 1082 • ACR Convergence 2021
The Rheumatology Workforce in Canada: Results of the Workforce and Wellness Survey
Background/Purpose: A rheumatology workforce survey conducted in Canada in 2015 predicted a looming critical shortage of rheumatologists, with one third of surveyed rheumatologists indicating plans…Abstract Number: 155 • 2019 ACR/ARP Annual Meeting
A Prospective, Unblinded, Non-randomized Pilot Study Examining the Effect of a Musculoskeletal Immersion Curriculum for First Year Internal Medicine Residents
Background/Purpose: Musculoskeletal (MSK) disorders are one of the most common clinic visit complaints. Prior studies evaluating graduate medical training of rheumatology and MSK medicine have…Abstract Number: 259 • 2019 ACR/ARP Annual Meeting
Describing Treatment Patterns and Healthcare Costs in Newly Diagnosed Psoriatic Arthritis Patients by Physician Specialty
Background/Purpose: The clinical heterogeneity of psoriatic arthritis (PsA) presents a variety of diagnostic and treatment challenges, which may be reflected in the way different health…Abstract Number: 1213 • 2019 ACR/ARP Annual Meeting
A Retrospective Review and Prospective Intervention for Outpatient Follow-Up of Hospitalized Patients in Rheumatology
Background/Purpose: There is lack of appropriate outpatient follow-up (F/U) for hospitalized rheumatology patients, which can result in disease recurrence and recurrent inpatient admissions1. This is…Abstract Number: 2093 • 2019 ACR/ARP Annual Meeting
Safety of Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su, Shingrix) Among Patients with Autoimmune Inflammatory Diseases
Background/Purpose: HZ/su has been in use since 2017 and is recommended by the advisory committee on immunization practices (ACIP) as the preferred shingles vaccine due…Abstract Number: 2304 • 2019 ACR/ARP Annual Meeting
Bone Microstructure of Patients with Rheumatoid Arthritis: A HR-pQCT Study
Background/Purpose: In rheumatoid arthritis (RA), it has been reported that osteoclast are activated by immune complexes, anti-CCP antibodies (ACPAs), and inflammatory cytokines. The purpose of…Abstract Number: 191 • 2018 ACR/ARHP Annual Meeting
Creation of an Immunology Series Video Library in Facilitating Basic Immunology Knowledge Acquisition and Retention Amongst Adult Rheumatology Trainees
Background/Purpose: A strong foundational knowledge in immunology is key to understanding complex rheumatologic disease processes. Indeed, an immunology curriculum delivered by Rheumatology training programs across…Abstract Number: 97 • 2017 ACR/ARHP Annual Meeting
Medical Student Interest in Rheumatology As a Career
Background/Purpose: Based on data from the Rheumatology Workforce Study, there are insufficient rheumatologists to serve the needs of the population. Little is currently known about…Abstract Number: 912 • 2017 ACR/ARHP Annual Meeting
Has the Attractiveness of a Career in Rheumatology Changed for the Better? Comparison of Trends in the Rheumatology Fellowship Match from 2014 to 2017 with 2008 to 2013
Background/Purpose: Rheumatology has been a less attractive career choice than most other medical subspecialties for many years. The 2015 American College of Rheumatology (ACR)…Abstract Number: 2046 • 2017 ACR/ARHP Annual Meeting
Development and Validation of a Rheumatologist Satisfaction with Practice Scale –“ the Rheumatologist Satisfaction Scale” (RSS)
Background/Purpose: Practice improvement research routinely measures patient satisfaction and disease-specific outcomes but seldom considers the satisfaction of physicians who deliver the care. Studies suggest that…Abstract Number: 1599 • 2016 ACR/ARHP Annual Meeting
Speed of Onset of Effect on Patient-Reported Outcomes Assessed through Daily Electronic Patient Diaries in the Baricitinib Phase 3 RA Clinical Program
Background/Purpose: Baricitinib (bari), an oral Janus kinase (JAK) 1/JAK2 selective inhibitor, has demonstrated clinical efficacy with a satisfactory safety profile when administered once daily in…Abstract Number: 2029 • 2016 ACR/ARHP Annual Meeting
Risk of Knee Pain, Radiographic Osteoarthritis and Knee Arthroplasty in Retired Professional Footballers Compared to the General Population
Background/Purpose: To determine the prevalence of knee pain (KP), radiographic knee osteoarthritis (RKOA) and total knee replacements (TKR) in ex-professional footballers compared to general population…Abstract Number: 2584 • 2016 ACR/ARHP Annual Meeting
Prevalence of Anemia Among Rheumatoid Arthritis Patients Treated with Conventional Disease-Modifying Antirheumatic Drugs
Background/Purpose: Anemia in rheumatoid arthritis (RA) patients (pts) has a prevalence of 16%-64% depending on population and severity of disease1,2,3 and is more common…Abstract Number: 3023 • 2016 ACR/ARHP Annual Meeting
Lipid Profile and Effect of Statin Treatment in Pooled Phase 2 and Phase 3 Baricitinib Studies
Background/Purpose: In patients with active RA an increase in lipid analytes has been observed after treatment with janus kinase inhibitors and other disease-modifying antirheumatic drugs.1…